ResearcherComprehensive Cancer Center ViennaNo recent work listed
Florian Moik
Matched on ORCID iD 0000-0001-7738-4119; OpenAlex author ID A5067374686. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2021: 3 papers · 2022: 1 paper
Papers 4
- Patterns of Thromboembolism in Patients with Advanced Pancreatic Cancer Undergoing First-Line Chemotherapy with FOLFIRINOX or Gemcitabine/nab-Paclitaxel. Co-author DOI 10.1055/a-1548-4847↗
- Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis. Co-author DOI 10.1016/j.ejca.2021.03.040↗
- Hemostatic Biomarkers and Venous Thromboembolism Are Associated With Mortality and Response to Chemotherapy in Patients With Pancreatic Cancer. Co-author DOI 10.1161/atvbaha.121.316463↗
- Plasminogen activator inhibitor 1 and venous thrombosis in pancreatic cancer. Co-author DOI 10.1182/bloodadvances.2020003149↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Cihan Ay · 3 shared papers, 2021–2022 · strength 0.37
- Paper Hemostatic Biomarkers and Venous Thromboembolism Are Associated With Mortality and Response to Chemotherapy in Patients… DOI 10.1161/atvbaha.121.316463↗
- Paper Plasminogen activator inhibitor 1 and venous thrombosis in pancreatic cancer. DOI 10.1182/bloodadvances.2020003149↗
- Paper Patterns of Thromboembolism in Patients with Advanced Pancreatic Cancer Undergoing First-Line Chemotherapy with FOLFIRI… DOI 10.1055/a-1548-4847↗
- Nigel Mackman · 2 shared papers, 2021 · strength 0.25
- Ingrid Pabinger · 2 shared papers, 2021 · strength 0.25
- Michael Stotz · 2 shared papers, 2021–2022 · strength 0.23
- Paper Patterns of Thromboembolism in Patients with Advanced Pancreatic Cancer Undergoing First-Line Chemotherapy with FOLFIRI… DOI 10.1055/a-1548-4847↗
- Paper Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A prope… DOI 10.1016/j.ejca.2021.03.040↗
- Armin Gerger · 2 shared papers, 2021–2022 · strength 0.23
- Paper Patterns of Thromboembolism in Patients with Advanced Pancreatic Cancer Undergoing First-Line Chemotherapy with FOLFIRI… DOI 10.1055/a-1548-4847↗
- Paper Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A prope… DOI 10.1016/j.ejca.2021.03.040↗
- Jakob Michael Riedl · 2 shared papers, 2021–2022 · strength 0.23
- Paper Patterns of Thromboembolism in Patients with Advanced Pancreatic Cancer Undergoing First-Line Chemotherapy with FOLFIRI… DOI 10.1055/a-1548-4847↗
- Paper Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A prope… DOI 10.1016/j.ejca.2021.03.040↗
- Martin Pichler · 2 shared papers, 2021–2022 · strength 0.23
- Paper Patterns of Thromboembolism in Patients with Advanced Pancreatic Cancer Undergoing First-Line Chemotherapy with FOLFIRI… DOI 10.1055/a-1548-4847↗
- Paper Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A prope… DOI 10.1016/j.ejca.2021.03.040↗
- Dominik Andreas Barth · 2 shared papers, 2021–2022 · strength 0.23
- Paper Patterns of Thromboembolism in Patients with Advanced Pancreatic Cancer Undergoing First-Line Chemotherapy with FOLFIRI… DOI 10.1055/a-1548-4847↗
- Paper Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A prope… DOI 10.1016/j.ejca.2021.03.040↗
- Konstantin Schlick · 2 shared papers, 2021–2022 · strength 0.23
- Paper Patterns of Thromboembolism in Patients with Advanced Pancreatic Cancer Undergoing First-Line Chemotherapy with FOLFIRI… DOI 10.1055/a-1548-4847↗
- Paper Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A prope… DOI 10.1016/j.ejca.2021.03.040↗
- Richard Greil · 2 shared papers, 2021–2022 · strength 0.23
- Paper Patterns of Thromboembolism in Patients with Advanced Pancreatic Cancer Undergoing First-Line Chemotherapy with FOLFIRI… DOI 10.1055/a-1548-4847↗
- Paper Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A prope… DOI 10.1016/j.ejca.2021.03.040↗
- J. Thaler · 1 shared paper, 2021 · strength 0.13
- Gerald W. Prager · 1 shared paper, 2021 · strength 0.13
- Yohei Hisada · 1 shared paper, 2021 · strength 0.12
- Tomohiro Kawano · 1 shared paper, 2021 · strength 0.12
- Matthew J. Flick · 1 shared paper, 2021 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.